Speakers: Doctor C. Ballantyne (Houston, US) , Doctor S. Chatur (Calgary, CA) , Professor J. Januzzi (Boston, US) , Doctor P. Lopez Ayala (Basel, CH)
Focus on
- Understand the diagnostic performance of cardiac myosin-binding protein C for the early diagnosis of myocardial infarction in combination with high sensitivity cardiac troponin and how dual and single biomarker strategies compare
- Learn why and when measuring Lp(a) levels is important, how results should be interpreted and what clinical decisions can be informed, what treatment options are available and upcoming
- Learn how to identify heart failure in preclinical stages, in asymptomatic patients at high risk for progression, and what real-world evidence exists on the uptake and utility of natriuretic peptide-based screening in adults with diabetes
- Understand the role of serial NT-proBNP measurements in the outpatient setting, for heart failure therapy titration and longitudinal risk monitoring, and learn about upcoming home testing solutions
5 December 2024
Time 18:00 to 19:00 CET
